Type II Transmembrane Serine Proteases

被引:270
作者
Bugge, Thomas H. [1 ]
Antalis, Toni M. [2 ,3 ]
Wu, Qingyu [4 ,5 ]
机构
[1] NIH, Proteases & Tissue Remodeling Sect, NIDCR, Bethesda, MD 20892 USA
[2] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA
[4] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA
[5] Cleveland Clin, Lerner Res Inst, Dept Nephrol, Cleveland, OH 44195 USA
基金
美国国家卫生研究院;
关键词
HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR-1B; PROSTATE-CANCER PROGRESSION; EPITHELIAL SODIUM-CHANNEL; CELL-SURFACE; GENE FUSION; PLASMINOGEN-ACTIVATOR; MATRIPTASE-2; TMPRSS6; FUNCTIONAL-ANALYSIS; IRON-DEFICIENCY;
D O I
10.1074/jbc.R109.021006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Analysis of genome and expressed sequence tag data bases at the turn of the millennium unveiled a new protease family named the type II transmembrane serine proteases (TTSPs) in a Journal of Biological Chemistry minireview (Hooper, J. D., Clements, J. A., Quigley, J. P., and Antalis, T. M. (2001) J. Biol. Chem. 276, 857-860). Since then, the number of known TTSPs has more than doubled, and more importantly, our understanding of the physiological functions of individual TTSPs and their contribution to human disease has greatly increased. Progress has also been made in identifying molecular substrates and endogenous inhibitors. This minireview summarizes the current knowledge of the rapidly advancing TTSP field.
引用
收藏
页码:23177 / 23181
页数:5
相关论文
共 61 条
  • [1] Afar DEH, 2001, CANCER RES, V61, P1686
  • [2] Ichthyosis, Follicular Atrophoderma, and Hypotrichosis Caused by Mutations in ST14 Is Associated with Impaired Profilaggrin Processing
    Alef, Thomas
    Torres, Serena
    Hausser, Ingrid
    Metze, Dieter
    Tuersen, Uemit
    Lestringant, Gilles G.
    Hennies, Hans Christian
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (04) : 862 - 869
  • [3] Activation of epithelial sodium channels by mouse channel activating proteases (mCAP) expressed in Xenopus oocytes requires catalytic activity of mCAP3 and mCAP2 but not mCAP1
    Andreasen, Ditte
    Vuagniaux, Gregoire
    Fowler-Jaeger, Nicole
    Hummler, Edith
    Rossier, Bernard C.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (04): : 968 - 976
  • [4] Autosomal recessive ichthyosis with hypotrichosis caused by a mutation in ST14, encoding type II transmembrane serine protease matriptase
    Basel-Vanagaite, Lina
    Attia, Revital
    Ishida-Yamamoto, Akemi
    Rainshtein, Limor
    Ben Amitai, Dan
    Lurie, Raziel
    Pasmanik-Chor, Metsada
    Indelman, Margarita
    Zvulunov, Alex
    Saban, Shirley
    Magal, Nurit
    Sprecher, Eli
    Shohat, Mordechai
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2007, 80 (03) : 467 - 477
  • [5] Matriptase-dependent cell surface proteolysis in epithelial development and pathogenesis
    Bugge, Thomas H.
    List, Karin
    Szabo, Roman
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 5060 - 5070
  • [6] TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions
    Cerveira, Nuno
    Ribeiro, Franclim R.
    Peixoto, Ana
    Costa, Vera
    Henrique, Rui
    Jeronimo, Carmen
    Teixeira, Manuel R.
    [J]. NEOPLASIA, 2006, 8 (10): : 826 - 832
  • [7] Hypertension in mice lacking the proatrial natriuretic peptide convertase corin
    Chan, JCY
    Knudson, O
    Wu, FY
    Morser, J
    Dole, WP
    Wu, QY
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (03) : 785 - 790
  • [8] Human airway trypsin-like protease induces amphiregulin release through a mechanism involving protease-activated receptor-2-mediated ERK activation and TNF α-converting enzyme activity in airway epithelial cells
    Chokki, M
    Eguchi, H
    Hamamura, I
    Mitsuhashi, H
    Kamimura, T
    [J]. FEBS JOURNAL, 2005, 272 (24) : 6387 - 6399
  • [9] TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
    Demichelis, F.
    Fall, K.
    Perner, S.
    Andren, O.
    Schmidt, F.
    Setlur, S. R.
    Hoshida, Y.
    Mosquera, J-M
    Pawitan, Y.
    Lee, C.
    Adami, H-O
    Mucci, L. A.
    Kantoff, P. W.
    Andersson, S-O
    Chinnaiyan, A. M.
    Johansson, J-E
    Rubin, M. A.
    [J]. ONCOGENE, 2007, 26 (31) : 4596 - 4599
  • [10] Delineation of prognostic biomarkers in prostate cancer
    Dhanasekaran, SM
    Barrette, TR
    Ghosh, D
    Shah, R
    Varambally, S
    Kurachi, K
    Pienta, KJ
    Rubin, MA
    Chinnaiyan, AM
    [J]. NATURE, 2001, 412 (6849) : 822 - 826